Advertisement
Journal Home
Search for

Volume 192, Issue 5, Pages e8-e11 (November 2006)


View previous. 29 of 39 View next.

Transmetatarsal amputation: assessment of current selection criteria

Presented at the 30th Annual Surgical Symposium of the Association of VA Surgeons, Cincinnati, Ohio, May 7–9, 2006

Thomas Anthony, M.D.aCorresponding Author Informationemail address, James Roberts, P.A.-C.a, J. Gregory Modrall, M.D.b, Sergio Huerta, M.D.a, Massimo Asolati, M.D.a, John Neufeld, M.D.c, Betty Parker, R.N.a, Weibin Yang, M.D.d, George Sarosi, M.D.a

Received 5 May 2006; received in revised form 3 August 2006

Abstract 

Background

Transmetatarsal amputation (TMA) is an operation designed to remove a limited area of irremediable tissue ischemia and/or infection and preserve limb function. Patients are selected for TMA based on degree of tissue loss/infection, adequacy of tissue perfusion at the transmetatarsal level, current ambulatory status, and estimation of the likelihood of postprocedure ambulation. The purpose of this study was to assess the validity of these selection criteria.

Methods

An institutional review board–approved retrospective review was conducted of all patients undergoing TMA from January 1, 1997, until January 1, 2006. Information was collected on patient demographics, medical comorbidity, and clinical and surgical variables. Outcome measures included the proportion of patients requiring amputation revision to a more proximal level and ambulatory status at last follow-up.

Results

Fifty-two TMAs were performed. In 35 procedures, the skin was left open, and in 17 TMA was closed primarily. Primary indications for the procedure were vascular insufficiency or infection in 50 of 52 patients, whereas 2 patients required amputation for malignancy. The majority (46/52, 89%) of patients were diabetic. After the index TMA, 85 additional operations were required. Only 9 patients (18%) underwent a single operation. Revision of the TMA to a more proximal level was required in 29 of 52 (56%) patients, resulting in 4 Syme, 20 transtibial, and 5 transfemoral amputations. Non–insulin-dependent diabetes was associated with an increased likelihood of revision to a more proximal amputation (odds ratio [OR] = 5.4; 95% confidence interval [CI], 1.2–24). At the time of last follow-up (median 18 months), 37 of 50 (74%) patients were ambulatory (83% for TMAs and 67% for more proximal amputations, P = 0.18). Prior vascular procedures were associated with a significantly decreased likelihood of ambulation (OR = 14; 95% CI, 1.9–103).

Conclusions

Although most patients retain the ability to ambulate after TMA, multiple operations should be anticipated in the majority of patients and revision of a TMA to a more proximal level may be required. These data suggest that current selection criteria for TMA may be inadequate.

a Section of General Surgery, Surgical Service, VA North Texas Health Care System, 4500 S Lancaster Rd, Dallas, TX 75216, USA

b Section of Vascular Surgery, Surgical Service, VA North Texas Health Care System, Dallas, TX, USA

c Section of Orthopedic Surgery, Surgical Service, VA North Texas Health Care System, Dallas, TX, USA

d Physical Medicine and Rehabilitation Service, VA North Texas Health Care System, Dallas, TX, USA

Corresponding Author InformationCorresponding author. Tel.: +1-214-857-1800; fax: +1-214-857-1891.

PII: S0002-9610(06)00501-0

doi:10.1016/j.amjsurg.2006.08.011


View previous. 29 of 39 View next.

Advertisement